OncoTracker Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $150K

OncoTracker General Information

Description

Provider of medical diagnostics services intended to detect and cure cancer and other diseases. The company's assay is based on measuring B-cell maturation antigen (BCMA) and helps in monitoring and predicting outcomes for multiple myeloma and chronic lymphocytic leukemia patients, enabling doctors to rapidly and accurately assess changes in a patient's cancer and further predict treatment efficacy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 9201 Sunset Boulevard
  • Suite 307
  • West Hollywood, CA 90069
  • United States
+1 (424)
Primary Industry
Drug Discovery
Other Industries
Laboratory Services (Healthcare)
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 9201 Sunset Boulevard
  • Suite 307
  • West Hollywood, CA 90069
  • United States
+1 (424)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OncoTracker Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 13-Feb-2020 $150K Completed Generating Revenue
2. Later Stage VC 13-Mar-2019 Completed Generating Revenue
1. Seed Round 10-Nov-2016 $1.12M $1.12M Completed Generating Revenue
To view OncoTracker’s complete valuation and funding history, request access »

OncoTracker Patents

OncoTracker Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3873478-A2 Method of enhancing immune-based therapy Pending 31-Oct-2018
US-20220000872-A1 Method of enhancing immune-based therapy Pending 31-Oct-2018
EP-3873478-A4 Method of enhancing immune-based therapy Pending 31-Oct-2018
US-20200264184-A1 Diagnostic, prognostic, and monitoring methods for solid tumor cancers Active 13-Jun-2017
US-11635435-B2 Diagnostic, prognostic, and monitoring methods for solid tumor cancers Active 13-Jun-2017 C07K16/2878
To view OncoTracker’s complete patent history, request access »

OncoTracker Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OncoTracker FAQs

  • When was OncoTracker founded?

    OncoTracker was founded in 2014.

  • Where is OncoTracker headquartered?

    OncoTracker is headquartered in West Hollywood, CA.

  • What is the size of OncoTracker?

    OncoTracker has 4 total employees.

  • What industry is OncoTracker in?

    OncoTracker’s primary industry is Drug Discovery.

  • Is OncoTracker a private or public company?

    OncoTracker is a Private company.

  • What is OncoTracker’s current revenue?

    The current revenue for OncoTracker is .

  • How much funding has OncoTracker raised over time?

    OncoTracker has raised $1.3M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »